Press Release

Revital Healthcare’s Largest Rapid Test Kit Production Facility in Africa launched by U.S. Ambassador Meg Whitman

Revital Healthcare proudly stands as Africa’s premier manufacturer of rapid test kits, leading the region in healthcare innovation.

Official Press Release

May 7, 2024 – Kilifi, Kenya
Revital Healthcare’s Largest Rapid Test Kit Production Facility in Africa launched by U.S. Ambassador Meg Whitman

In a groundbreaking development for the health sector in Africa, Revital Healthcare today unveiled its state-of-the-art rapid test kit production facility in Kilifi, Kenya (Africa). Equipped through a co-funding mechanism between the United States Agency for International Development (USAID) and Revital Healthcare, the facility will have the capacity to produce 20 million test kits a month. These test kits include HIV-1/2, Malaria P.f/Pan, HCG, Hepatitis B/C, Dengue, and Syphilis among others. Revital Healthcare is the first end-to-end manufacturer of rapid diagnostic tests (RDTs) across Sub-Saharan Africa, with these kits intended to reach a population of over a billion across the continent. The launch event was attended by U.S. Ambassador to Kenya Meg Whitman, Cabinet Secretary Susan Nakhumicha, Principal Secretary Dr. Juma Mukhwana, Kilifi County Governor Gideon Maitha Mung’aro, and other delegates from Kenya and Internationally.

Speaking at the launch U.S. Ambassador to Kenya Meg Whitman noted, “Revital’s Rapid Diagnostic Test manufacturing facility, the first of its kind in Kenya, is a game-changer. By bringing cutting-edge technology and local expertise together under one roof, Revital is not just producing essential diagnostic tests, they’re rewriting the script on what’s possible when it comes to expanding access to quality healthcare in Africa.”

Revital Healthcare Chairman added, “Our goal is to ensure that we produce testing technology that is efficient and affordable across the continent. We have expanded to become the largest manufacturer of medical devices on the African continent with a manufacturing capacity of 2.1 billion medical devices per year, including manufacturers of Africa’s 1st USFDA certified and patented auto-disable syringes. Revital Healthcare is currently exporting our products to over 29 countries globally as our team focuses on ensuring our global expansion to support communities across Africa with high-quality and affordable medical devices .”

Like other developing countries, Kenya’s health system is burdened by communicable and non-communicable diseases, and the country faces one of the highest prevalence of non-communicable diseases in sub-Saharan Africa. Kenya is a promising market for medical devices and has been ranked as one of the fastest-growing markets in the sub-Saharan Africa region based on reports from the World Bank.

The medical device sector is heavily reliant on imports with limited domestic production due to limited manufacturing infrastructure and technical capacity, and limited access to raw materials. The sector is however anticipated to grow with the rising need for self-testing kits, especially after the Kenyan Government’s approved licensing for rapid diagnostic tests (RDTs) for Malaria, HIV, and COVID-19.

Decreasing the financial burden on the Ministry of Health to provide medical devices and equipment at international health standards to most hospitals and clinics in the country requires an expansion of the domestic production capacity. The production of basic consumables remains low, providing opportunities for manufacturers of medical products such as bandages and dressings, suturing materials, catheters, syringes, surgical gloves, and blood grouping reagents. Currently, up to 90 percent of all consumables are imported from China and India.

The COVID-19 pandemic demonstrated the acute dangers to sustainable healthcare in developing countries reliant on high levels of imports. Revital Healthcare’s production facility is therefore timely and important as this supports the global agenda to build capacity for essential medical commodities through targeted investments by USAID to support the development of healthcare security for the African continent.

USAID’s partnership with Revital Healthcare will see the company significantly increase its production volumes which will in turn boost export volumes to Uganda, Tanzania, DRC, South Sudan, and Congo while establishing a commercial presence in Nigeria and Ethiopia through product registration and certification. Additionally, the facility will create 200 new full-time jobs with 80 percent being women while having a focus on speech and hearing-impaired individuals.

1st

Spearheading Rapid Test Kit Revolution

Revital Healhtcare leads the charge in rapid test kit innovation, offering a comprehensive range for diseases like HIV, Malaria, and more.

Setting Benchmarks in RDT Production

Revital’s state-of-the-art facility boasts unmatched capacity, producing 20 million rapid test kits monthly, ensuring timely disease detection.

Redefining Healthcare Accessibility

Revital’s commitment to affordability and scalability expands access to vital rapid test kits, empowering communities across Africa to combat diseases effectively.

Reactions

Buzz on Revital Healthcare’s Monumental Launch

“Revital’s Rapid Diagnostic Test manufacturing facility, the first of its kind in Kenya, is a game-changer. By bringing cutting-edge technology and local expertise together under one roof, Revital is not just producing essential diagnostic tests, they’re rewriting the script on what’s possible when it comes to expanding access to quality healthcare in Africa.”

Meg Whitman

U.S. Ambassador to Kenya

“Our goal is to ensure that we produce testing technology that is efficient and affordable across the continent. We have expanded to become the largest manufacturer of medical devices on the African continent with a manufacturing capacity of 2.1 billion medical devices per year, including manufacturers of Africa’s 1st USFDA certified and patented auto-disable syringes. Revital Healthcare is currently exporting our products to over 29 countries globally as our team focuses on ensuring our global expansion to support communities across Africa with high-quality and affordable medical devices.”

Rajni Vora

Chairman and Founder, Revital Healthcare EPZ Ltd

“This is not just an investment in Kenya’s future, building a skilled workforce and creating a hub for medical innovation in Africa, it’s also creating significant employment opportunities for the people of Kilifi county. This facility will be a major job creator, providing skilled positions in manufacturing, logistics, and research, translating to improved livelihoods for our communities and a boost to the local economy,”

Gideon Mung'aro

Governor of Kilifi County

Moments of Grandeur & Innovation

Have Any Questions?

FAQ’s

Bridging Healthcare Gaps: Revolutionizing Access to Rapid Testing

Explore how Revital Healthcare’s new facility is leveling the healthcare playing field across Africa through accessible and timely diagnostics, ensuring RDTs reach those who need them most.

What is Revital Healthcare's new rapid test kit production facility, all about?

Revital Healthcare has inaugurated a cutting-edge rapid test kit production facility in Kilifi, Kenya. This facility is set to manufacture a range of essential rapid diagnostic tests, including HIV, Malaria, Hepatitis, Pregnancy and more, aiming to address healthcare needs across Africa.

How does this facility contribute to healthcare accessibility in Africa?

By locally manufacturing rapid diagnostic tests (RDTs), Revital Healthcare aims to enhance accessibility to essential healthcare services across Africa. With a capacity to produce 20 million test kits monthly, the facility intends to serve over a billion people on the continent, thereby reducing dependence on imports and ensuring timely access to critical medical supplies.

What distinguishes Revital Healthcare's rapid test kits from others on the market?

Revital Healthcare’s rapid test kits stand out for their quality, affordability, and local production. Being the first end-to-end manufacturer of RDTs in Sub-Saharan Africa, Revital ensures that its products meet international standards while remaining cost-effective, making healthcare more accessible to underserved communities.

How does this initiative align with global health security goals?

Revital Healthcare’s initiative aligns with global health security goals by strengthening local healthcare infrastructure and reducing dependence on imports, especially for essential medical supplies. By expanding domestic production capacity, this initiative contributes to building resilience against health emergencies like the COVID-19 pandemic and ensures sustainable healthcare systems in Africa.

What are the socio-economic impacts of this project?

The launch of Revital Healthcare’s rapid test kit production facility not only signifies a milestone in healthcare innovation but also generates positive socio-economic impacts. By creating 200 new full-time jobs, particularly for women and individuals with disabilities, and focusing on local production, this project contributes to economic empowerment and social inclusion in the region.

Blog

Latest News & Resources

WHO PQS

WHO PQS

Press ReleaseRevital Healthcare EPZ Ltd. Achieves WHO Prequalification for Early-Activation Auto-Disable Syringe: A Milestone for African Manufacturing and Immunization ProgrammingRevital Healthcare EPZ Ltd. stands as the exclusive African manufacturer granted WHO PQ...

Revital banks blanket contract from a key global organisation

Revital banks blanket contract from a key global organisation

Blog News &UpdatesRevital Healthcare banks blanket contractfrom a key global organisationRevital Healthcare has recently secured a notable contract with a global organization to supply India with 50 million units of 2ML vaccine syringes amidst concerns over a...

Ukraine using Revital-made bCPAP device to save premature babies

Ukraine using Revital-made bCPAP device to save premature babies

Blog News &UpdatesUkraine using Revital-made bCPAP device to save premature babiesPremature babies in Ukraine with breathing difficulties are being saved by a device made in Kenya. The bCPAP device, produced by Africa's largest medical manufacturer - Revital...